The Russian government is considering providing support to the domestic pharmaceutical producers planning to export their drugs, according to recent statements by Russia’s Prime-Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent. 1 August 2016
The Irish Pharmaceutical Healthcare Association (IPHA) has agreed a new four-year “Framework Agreement” with the government for an economic and secure supply of medicines for patients. The Agreement will see total savings of 785 million euros ($862 million) from IPHA member companies, an average of nearly 200 million euros a year. 25 July 2016
The Venezuelan government has established automatic distribution centers as part of a project to improve medical supplies in the South American country. 25 July 2016
The Association of the British Pharmaceutical Industry (ABPI) has hit back after the leader of the Labour Party said pharmaceutical companies should not be allowed to become ‘too dominant’ over the NHS. 21 July 2016
With the swearing-in of the new Australian federal ministry this week, it is anticipated that work will resume to deliver the National Innovation and Science Agenda. 21 July 2016
The UK government remains tight-lipped on whether a new Life Sciences Minister will be appointed to replace George Freeman MP, who was moved to a different department last week. 18 July 2016
Ensuring better access to drugs and improved health care innovation should be top of the agenda at an annual meeting of Canada's Premiers this week, according to industry group the Canadian Pharmacists Association (CPhA). 18 July 2016
The King of Spain, Felipe VI, last week received members of the pharma trade group Farmaindustria in an official audience at the Palace, when the monarch got to directly learn about the activity of a sector gathered by 180 companies, in which national and international big, medium and small size enterprises share a common space. 18 July 2016
The head of Eisai in Europe has pledged to subsidize the cost of thyroid cancer drug Lenvima (lenvatinib) if health bosses agree to include it in the revamped Cancer Drugs Fund (CDF). 14 July 2016
The UK government has brought in pharma industry chiefs to co-chair a ministerial group aimed at ensuring Brexit does not damage the country’s life sciences sector. 11 July 2016
Knowing when to prescribe biosimilars is a massive issue internationally, and action is being taken on the issue in the UK to make sure they are used appropriately and in consultation with patients. 8 July 2016
As European Union member states vie to get re-location of the European Medicines Agency to their country following the UK referendum vote to leave the EU, Spain being the latest to pitch its case, the EMA acknowledges the outcome and says it is now up to the UK government to decide how to act. 7 July 2016
The Spanish government has confirmed its interest in Spain hosting the European Medicines Agency (EMA) if it moves from its current UK base following the vote for Brexit in last month’s referendum. 6 July 2016
A group of four pharma industry associations have signed a memorandum of understanding in China to adopt pro-medicine and patient-centered principles, build public consensus on the value of medical representatives and establish a national system to manage them, and promote proper and orderly development of the sector. 29 June 2016
The boss of one of Europe’s leading biotech companies tells The Pharma Letter that it cannot now consider teaming up with UK researchers because of fears that such partnerships will lose European Union (EU) funding. 27 June 2016
Britain's unexpected vote on Thursday to leave the European Union, which saw currency and stock markets in turmoil in Friday, has left many scrambling to determine the impact on markets and various sectors. 26 June 2016
The Russian government has appointed the National immuno-biological company (Natsimbio), the recently established Russian drugmaker which is part of the Russian state and defense corporation Rostec, as sole supplier of blood plasma drugs for the period of 2016-2017 years through the signing of a contract with the company. 24 June 2016
As reported earlier today, the UK has voted to leave the European Union, with the news sending sterling and stocks into turmoil, as well as the resignation of Prime Minister David Cameron. 24 June 2016
The UK has spoken. The Referendum on Thursday, which saw a massive turnout of over 70%, resulted in a vote to leave the European Union. A total of 51.9%, or 17,410,742 people voted to Leave, compared with 48.1%, or 16,141,241people who voted Remain. 24 June 2016
The Indian government has withdrawn a Bill introduced in 2013 to amend the existing Drugs and Cosmetics Act, promising to ‘comprehensively review’ regulations to suit new science and research methods. 23 June 2016
The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will come into force in 2025. 1 October 2024
The Danish government is to remove the rules that currently prohibit the purchase of medicines from countries outside the European Union (EU) in a move that has not been welcomed by pharma. 30 September 2024
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). 30 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
US biotech Emergent BioSolutions revealed it has secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox and mpox product portfolio. 26 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
President Biden has said the USA will commit at least $500 million to support African countries in battling the ongoing mpox outbreak in Central and Eastern Africa. 25 September 2024
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance. 23 September 2024
Basilea Pharmaceutica announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) has awarded Basilea an Other Transaction Agreement (OTA), under OTA number 75A50124C00033. 20 September 2024
Novo Nordisk is under increasing pressure over the cost of its blockbuster drugs in the USA, as chief executive Lars Fruergaard Jørgensen prepares to testify before a powerful Senate committee. 18 September 2024
The research based pharmaceutical industry has welcomed Mario Draghi’s report, published by the European Commission, outlining proposals on how Europe can regain its competitive edge and the critical role of innovative industries in achieving this. 11 September 2024
Even as emerging signs of a thaw in the broader Indian start-up funding landscape were evident, the Competition Commission of India (CCI) has tightened its exemption list under new combination rules. 11 September 2024
The US House of Representatives has passed the BIOSECURE Act, gaining bipartisan support with a vote of 306–81. Nearly all of the votes against the bill came from Democrats. 10 September 2024
The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted what it regards as the UK's potential to lead the global cell and gene therapy sector. 5 September 2024
The budget on October 30 is an opportunity to end short-termism, cut waste, and attract long-term investment to the country’s economy with a sector-targeted R&D tax relief policy, according to the UK BioIndustry Association (BIA). 3 September 2024
The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government financial bill setting out new priorities in health in 2025. 2 September 2024
Marseille-based ImCheck Therapeutics has received 20.2 million euros ($22.4 million) in non-dilutive funding as part of the i-Démo call for projects under the France 2030 Plan operated by Bpifrance on behalf of the French government. 29 August 2024